Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunic Inc
(NQ:
IMUX
)
1.120
+0.010 (+0.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,195,350
Open
1.130
Bid (Size)
1.110 (50)
Ask (Size)
1.280 (2)
Prev. Close
1.110
Today's Range
1.060 - 1.340
52wk Range
0.9451 - 3.110
Shares Outstanding
26,249,439
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Peek Behind the Curtain: 7 Penny Stocks With Heavy Insider Buying
May 23, 2024
While speculative ideas are treacherous, you can possibly reduce your blood pressure with these penny stocks with insider buying.
Via
InvestorPlace
Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
May 20, 2024
Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses the importance of clinical trials in the biotech industry to mark Clinical Trials Day on May 20.
Via
TheNewswire.com
Performance
YTD
-22.76%
-22.76%
1 Month
-9.68%
-9.68%
3 Month
-17.65%
-17.65%
6 Month
-22.76%
-22.76%
1 Year
-51.93%
-51.93%
More News
Read More
Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
May 20, 2024
Via
News Direct
Immunic chief medical officer discusses promising treatments to mark World IBD Day
May 17, 2024
Via
News Direct
Immunic chief medical officer discusses promising treatments to mark World IBD Day
May 17, 2024
Via
TheNewswire.com
IMUX Stock Earnings: Immunic Misses EPS for Q1 2024
May 08, 2024
Via
InvestorPlace
Immunic's Earnings Outlook
February 21, 2024
Via
Benzinga
Immunic: Q3 Earnings Insights
November 14, 2023
Via
Benzinga
A Preview Of Immunic's Earnings
November 13, 2023
Via
Benzinga
Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day
May 16, 2024
Via
News Direct
Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day
May 16, 2024
Via
TheNewswire.com
Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones
May 09, 2024
Via
News Direct
Topics
Intellectual Property
Exposures
Intellectual Property
Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones
May 09, 2024
Via
TheNewswire.com
Topics
Intellectual Property
Exposures
Intellectual Property
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
May 01, 2024
Via
News Direct
Immunic "super excited" about latest PMS trial data
October 11, 2023
Via
News Direct
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
May 01, 2024
Via
TheNewswire.com
Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
March 21, 2024
Via
News Direct
Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
March 21, 2024
Via
TheNewswire.com
Immunic And 2 Other Stocks Under $2 Insiders Are Buying
February 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With Immunic Stock?
January 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 05, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 05, 2024
Via
InvestorPlace
Immunic CSO hails "great" progress with MS program
October 24, 2023
Via
News Direct
Immunic CSO hails "great" progress with MS program
October 24, 2023
Via
TheNewswire.com
Immunic "super excited" about latest PMS trial data
October 11, 2023
Via
TheNewswire.com
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
